| Typ : |
Zeitung |
| Internet-Link : |
https://doi.org/10.1007/s40268-023-00433-7 |
|
| Forschungsgruppen : |
Incheon - Quality Evaluation Team, Samsung Bioepis Co |
| Autoren : |
Tak M, Jeong H, Yun J, Kim J, Kim S, Lee Y, Park S-J. |
| Titel : |
In‑Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period. |
| Veröffentlichung : |
Drugs R D ;23,4:363 - 375 2023 |
|
| Niveau von Beweisen : |
|
| Physikalische Stabilität : |
|
| Chemische Stabilität : |
|
| Andere Verfahren : |
|
| Kommentare : |
| Proteine: biologische Aktivität mittels enzymatischer Technik |
|
Molekülverzeichnis
 Eculizumab
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
5 mg/ml |
2-8°C |
 |
| 90 |
 |
|
 |
|
|
|
5 mg/ml |
28-32°C |
|
| 72 |
 |
|
|
|
|
 |
5 mg/ml |
2-8°C |
|
| 90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
| 72 |
|
|
|
|
 |
|
5 mg/ml |
2-8°C |
|
| 90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
| 72 |
|
|
|
|
|
|
5 mg/ml |
2-8°C |
|
| 90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
| 72 |
|
|
|
|
|
